Ledger.Open graph →
SEC Form D · filed February 12, 2021

Synaptogenix, Inc

Offering
$14.0M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

William N. Singer · New York, NYDirectorJoshua N. Silverman · New York, NYDirectorJonathan L. Schechter · New York, NYDirectorGeorge T. Perry · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorDaniel A. Alkon · New York, NYExec · DirectorAlan J. Tuchman · New York, NYExec · DirectorRobert J. Weinstein · New York, NYExecJonathan L. Schechter · New York, NYDirectorGeorge T. Perry · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorWilliam N. Singer · New York, NYDirectorJoshua N. Silverman · New York, NYDirectorDaniel A. Alkon · New York, NYExec · DirectorAlan J. Tuchman · New York, NYExec · DirectorRobert J. Weinstein · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗